COM:CITIUSPHARMA
Citius Pharmaceuticals, Inc.
- Stock
Last Close
0.17
22/11 21:00
Market Cap
25.79M
Beta: -
Volume Today
15.99M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -2.90M - | -8.30M 185.84% | -10.38M 25.18% | -12.54M 20.72% | -15.56M 24.13% | -17.55M 12.76% | -23.05M 31.38% | -33.64M 45.92% | -32.54M 3.26% | |
depreciation and amortization | 1.34K - | 1.75K - | 893 49.06% | 152.36K 16,962.04% | 164.87K 8.21% | 179.68K 8.98% | 194.32K 8.15% | |||
deferred income tax | 843.62K - | -450K - | -166.56K - | 576K 445.83% | 576K 0% | |||||
stock based compensation | 486.27K - | 732.15K 50.56% | 986.62K 34.76% | 779.70K 20.97% | 715.98K 8.17% | 803.26K 12.19% | 1.45M 81.13% | 3.91M 168.45% | 6.62M 69.40% | |
change in working capital | 362.68K - | 668.16K 84.23% | 115.52K 82.71% | 509.85K 341.36% | 2.20M 330.70% | -866.97K 139.48% | -2.72M 213.42% | 239.56K 108.82% | -4.01M 1,772.40% | |
accounts receivables | 818.34K - | |||||||||
inventory | -818.34K - | |||||||||
accounts payables | 452.98K - | 105.23K 76.77% | -306.73K 391.48% | 971.01K 416.57% | 1.14M 17.41% | -857.31K 175.20% | -579.14K 32.45% | -111.72K 80.71% | 1.76M 1,677.16% | |
other working capital | -90.31K - | 562.93K 723.37% | 422.24K 24.99% | -461.17K 209.22% | 1.06M 328.95% | -9.66K 100.92% | -2.14M 22,031.56% | 351.27K 116.43% | -5.77M 1,742.11% | |
other non cash items | -332.10K - | 150K 145.17% | 1.31M 774.41% | 377.20K 71.24% | 211.60K 43.90% | 528.77K 149.89% | 68K 87.14% | 378.20K 456.18% | 102K 73.03% | |
net cash provided by operating activities | -2.39M - | -5.90M 147.35% | -7.97M 35.10% | -11.32M 41.99% | -12.44M 9.89% | -16.93M 36.12% | -24.25M 43.23% | -28.36M 16.95% | -29.06M 2.46% | |
investments in property plant and equipment | -2.13K - | -1.83K - | -40.01M 2,184,877.50% | |||||||
acquisitions net | 255.75K - | |||||||||
purchases of investments | ||||||||||
sales maturities of investments | ||||||||||
other investing activites | ||||||||||
net cash used for investing activites | 255.75K - | -2.13K 100.83% | -1.83K - | -40.01M 2,184,877.50% | ||||||
debt repayment | -600K - | -164.58K - | -172.97K 5.10% | |||||||
common stock issued | 1.51M - | 5.43M 259.57% | 6.67M 22.94% | 16.17M 142.36% | 11.12M 31.22% | 15.58M 40.03% | 89.43M 474.11% | 13.80M - | ||
common stock repurchased | ||||||||||
dividends paid | ||||||||||
other financing activites | 435.20K - | 4.21M 867.38% | 1.13M 73.27% | 23.22K 97.94% | 7.49M 32,143.78% | 31.21M 316.96% | 31.27K - | |||
net cash used provided by financing activities | 1.51M - | 5.26M 248.65% | 10.88M 106.79% | 17.30M 58.94% | 11.15M 35.56% | 22.90M 105.41% | 120.47M 426.11% | 13.83M - | ||
effect of forex changes on cash | ||||||||||
net change in cash | -875.92K - | -381.79K 56.41% | 2.91M 862.14% | 5.98M 105.51% | -1.29M 121.58% | 5.97M 562.40% | 56.21M 842.23% | -28.36M 150.45% | -15.23M 46.30% | |
cash at beginning of period | 1.55M - | 676.14K 56.44% | 294.35K 56.47% | 3.20M 988.53% | 9.18M 186.63% | 7.89M 14.05% | 13.86M 75.58% | 70.07M 405.59% | 41.71M 40.47% | |
cash at end of period | 676.14K - | 294.35K 56.47% | 3.20M 988.53% | 9.18M 186.63% | 7.89M 14.05% | 13.86M 75.58% | 70.07M 405.59% | 41.71M 40.47% | 26.48M 36.51% | |
operating cash flow | -2.39M - | -5.90M 147.35% | -7.97M 35.10% | -11.32M 41.99% | -12.44M 9.89% | -16.93M 36.12% | -24.25M 43.23% | -28.36M 16.95% | -29.06M 2.46% | |
capital expenditure | -2.13K - | -1.83K - | -40.01M 2,184,877.50% | |||||||
free cash flow | -2.39M - | -5.90M 147.35% | -7.97M 35.13% | -11.32M 41.95% | -12.44M 9.89% | -16.93M 36.14% | -64.26M 279.49% | -28.36M 55.86% | -29.06M 2.46% |
All numbers in (except ratios and percentages)